Lifecore Biomedical, Inc. LFCR Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s accounts payable?
- Lifecore Biomedical, Inc. (LFCR) reported accounts payable of $7.01M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s accounts payable changed year-over-year?
- Lifecore Biomedical, Inc.'s accounts payable decreased by 14.7% year-over-year, from $8.22M to $7.01M.
- What is the long-term trend for Lifecore Biomedical, Inc.'s accounts payable?
- Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s accounts payable has grown at a -9.6% compound annual growth rate (CAGR), from $11.62M to $7.01M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.